Open AccessDisparity in public funding of systemic therapy for metastatic renal cell carcinoma within Canada
Author(s) -
Emily Jackson,
Sebastien J. Hotté
Publication year - 2022
Publication title -
canadian urological association journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.477
H-Index - 38
eISSN - 1920-1214
pISSN - 1911-6470
DOI - 10.5489/cuaj.7846
Subject(s) - pazopanib , medicine , sunitinib , formulary , temsirolimus , ipilimumab , cabozantinib , family medicine , lenvatinib , sorafenib , expanded access , renal cell carcinoma , cancer , oncology , apoptosis , biochemistry , chemistry , protein kinase b , immunotherapy , hepatocellular carcinoma , discovery and development of mtor inhibitors